Company Overview
Snapshot
Founded in March 2025, PGI operates with 1–10 employees and has completed one funding round. The company is currently in the R&D product stage, focusing on advanced DNA profiling solutions.
Business overview
PGI Defense Tech develops rapid, cost-effective, and highly accurate DNA profiling solutions tailored for military and law enforcement applications. The company integrates advanced forensic capabilities with global databases to enhance real-time field operations, improving decision-making in critical scenarios. PGI operates within the Aerospace, Defense & HLS sector, serving defense, safety & security, healthcare & life sciences, and government & city markets across Asia, Europe, and North America.
Strategic signal
In November 2024, PGI was featured in Calcalistech for its work in revolutionizing DNA diagnostics, highlighting the company's platform for personalized health. This signals PGI's potential to expand its advanced DNA profiling technology beyond defense applications into broader healthcare and life sciences markets, indicating a strategic validation of its core technology for diverse commercial applications.
Log in to access full profile ›Company Intelligence Q&A
- What is PGI's primary focus?
- PGI specializes in providing rapid, cost-effective, and highly accurate DNA profiling solutions for military and law enforcement applications, enhancing real-time field operations.
- When was PGI founded?
- PGI was founded in March 2025.
- What is the current product stage for PGI?
- PGI's product, Chen, is currently in the R&D stage, indicating that it is under active development and not yet commercially available. The company is focusing on refining its advanced DNA profiling capabilities.
- In which markets does PGI operate?
- PGI targets geomarkets in Asia, Europe, and North America, serving defense, safety & security, healthcare & life sciences, and government & city customers.
- What was a notable recent development for PGI?
- In November 2024, PGI was highlighted by Calcalistech for its platform that utilizes DNA testing to enable personalized health, showcasing its potential in revolutionizing DNA diagnostics.